ReviewDrugs2021

Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects.

Jerold Chun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.